GlassScriptPhysician profile
Urline Gregoire
NPI 1578914529
$4,895.14
in general payments reported to CMS, 2019-2025
38 companies · $1,312 in 2025
The $1,312 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $785 · 2022: $734 · 2023: $854 · 2024: $1,211 · 2025: $1,312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,376.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $689.65 | 2021-2025 | Xtandi, Myrbetriq, Padcev |
| Sumitomo Pharma America, INC. | $344.41 | 2023-2025 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $328.88 | 2021-2024 | Aveed, Xiaflex |
| Teleflex LLC | $328.18 | 2022-2024 | Urolift |
| 180 Medical, INC. | $322.40 | 2021-2025 | Gentlecath, Gentlecath Glide, Speedicath |
| Dentsply Ih Ab | $236.39 | 2023-2024 | Lofric, Lofric |
| Endo USA, INC. | $224.28 | 2024-2025 | Xiaflex, Aveed |
| Antares Pharma, INC. | $222.38 | 2021-2024 | Xyosted |
| Janssen Biotech, INC. | $216.21 | 2021-2025 | Erleada, Akeega |
| Tolmar, INC. | $156.67 | 2023-2025 | Eligard, Jatenzo |
| Myriad Genetic Laboratories, INC. | $142.54 | 2021-2025 | Prolaris |
| Immunitybio, INC. | $125.04 | 2024-2025 | |
| Accord Healthcare, INC. | $122.92 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $116.16 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $112.86 | 2022-2025 | Pylarify |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $103.45 | 2021-2025 | Lumenis Pulse 120h, Moses, Solyx Sis System |
| Coloplast Corp | $97.31 | 2023-2025 | Speedicath |
| Merck Sharp & Dohme LLC | $91.40 | 2024-2025 | Keytruda |
| Myovant Sciences INC. | $79.38 | 2021-2022 | |
| Abbvie INC. | $75.66 | 2021-2024 | |
| Abc Home Medical Supply, INC. | $75.01 | 2024 | |
| Bioprotect Medical, INC. | $71.08 | 2025 | Bioprotect Balloon Implant System |
| Urovant Sciences INC | $69.41 | 2021-2022 | |
| Convatec INC. | $66.93 | 2022-2025 | |
| Urogen Pharma, INC. | $64.44 | 2024 | |
| Dendreon Pharmaceuticals LLC | $50.38 | 2025 | Provenge |
| Kowa Pharmaceuticals America, INC. | $44.70 | 2022 | |
| Laborie Medical Technologies Corp. | $43.81 | 2022 | |
| Telix Pharmaceuticals | $42.54 | 2023-2025 | Illuccix |
| Mission Pharmacal Company | $40.56 | 2022-2023 | Uribel |
| Hollister Incorporated | $39.19 | 2021-2024 | Vapro Plus Pocket |
| Ethicon US, LLC | $32.83 | 2025 | Ethicon |
| C. R. Bard, INC. & Subsidiaries | $26.14 | 2024 | Bard Urinary Drainage Bag |
| Caris Mpi, INC. | $24.95 | 2025 | Mi Cancer Seek |
| Valencia Technologies Corporation | $20.34 | 2025 | Ecoin Device Kit |
| Tolmar Pharmaceuticals, INC. | $17.38 | 2021 | |
| Dentsply Ih INC. | $17.19 | 2022 | |
| Acerus Pharmaceuticals Corporation | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Urline Gregoire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.